In the BioHarmony Drug Report Database

"Preview" Icon

Micafungin

Micafungin, Mycamine (micafungin) is a small molecule pharmaceutical. Micafungin was first approved as Micafungin on 2005-03-16. It is used to treat candidemia and mycoses in the USA. It has been approved in Europe to treat candidiasis. Mycamine’s patent is valid until 2021-01-08 (FDA).

 

Trade Name

 

Mycamine
 

Common Name

 

micafungin
 

ChEMBL ID

 

CHEMBL457547
 

Indication

 

candidemia, candidiasis, mycoses
 

Drug Class

 

Antifungal antibiotics (undefined group)

Image (chem structure or protein)

Micafungin structure rendering